House Rx

What House Rx does

House Rx is a health technology and pharmacy services company founded in 2021 and headquartered in San Francisco that enables medically integrated dispensing of specialty medications inside oncology and rheumatology practices. The company deploys House Rx pharmacists and care coordinators directly into partner clinics, where they dispense oral specialty drugs as part of the patient's care team rather than routing prescriptions through external PBM-owned specialty pharmacies. This model targets the structural friction in traditional specialty pharmacy, including prior authorization delays of three to four weeks, mail-order fulfillment cycles averaging 27 days, medication adherence rates around 70%, and patient financial toxicity from high out-of-pocket costs.

The core product is a cloud-based pharmacy management platform, built by specialty pharmacists and physicians, that integrates with practice EHR systems to connect prescribers and pharmacists on a shared workflow. The platform comprises several modules: Script Management for prescription processing, Prior Authorization Automation using AI to consolidate data and pre-populate forms, Financial Assistance Workflows for copay and grant enrollment, Dispensing Analytics Dashboards for operational metrics, Patient Engagement Tools including pharmacist chat and refill coordination, and Drug Utilization Review for automated safety checking. In April 2025 the company announced what it describes as the first AI-enabled pharmacy management platform, incorporating HIPAA-compliant AI agents that automate eligibility verification, PA submission, and financial assistance enrollment. Underlying integrations include First Databank for drug data, Surescripts for eligibility and e-prescribing, CoverMyMeds for prior authorization services, and Moov for payment processing.

House Rx generates revenue through two primary streams: recurring program fees from partner clinics for managing medically integrated dispensing programs (with a contractual minimum of $1,000 per month per MID location) and subscription licensing of the pharmacy management platform technology. Distribution is direct-to-practice, with a field sales model targeting specialty clinics and channel expansion through industry advisors. By November 2025 the company operated across 80 clinic sites with 1,000+ providers, processing $1.5 billion in specialty prescriptions annually with a stated target to reach $3 billion by end of 2026, supported by approximately $100 million in total venture funding.

Name

House Rx

Legal name

House Rx, Inc.

Website

https://houserx.com

Company type

Private

Founded year

2021

Operating status

Operating

Headcount range

251–500 employees

Short description

House Rx is a San Francisco health technology company that partners with oncology and rheumatology practices to dispense specialty medications in-clinic, using an AI-enabled pharmacy management platform integrated with practice EHRs to accelerate prior authorizations, reduce fulfillment times, and improve medication adherence.

Ownership category

akta.pro rank

Product category

Specialty Pharmacy Management Software

NAICS

Offices of Physicians (62111), Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services (518)

SIC

Services-Prepackaged Software (7372)

akta.pro industry

PRIMARYHLALABAL

Virtual Pharmacy & Medication Management Integration Platforms

Healthcare & Life Sciences/Telehealth Platforms/Provider-Integrated Virtual Care Platforms (Health Systems/Clinics)

SECONDARYHLAEAKAL

PBM Technology Platforms (ePA/eRx/Real-Time Benefit Tools)

Healthcare & Life Sciences/Health Insurance & Managed Care/Pharmacy Benefit Management (PBM)

Keywords

• Specialty pharmacy platform
• Medically integrated dispensing
• Pharmacy management software
• Prior authorization automation
• In-clinic pharmacy services

Headquarters

HQ city

San Francisco

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure

Revenue model

1. Pharmacy Services & MID Program Fees: House Rx charges partner clinics program fees for implementing and managing medically integrated dispensing programs. The company provides turnkey pharmacy services including pharmacist staffing, pharmacy management technology, and operational support in exchange for recurring service fees.
2. Technology Platform Licensing: Revenue generated from licensing the proprietary pharmacy management platform to partner clinics, including EHR integration tools, analytics dashboards, and patient engagement features.

Pricing tiers

Go-to-market motion2 records

Distribution channels1 record

Marketing channels8 records

Core offering

House Rx provides a cloud-based pharmacy management platform that enables specialty medical practices to dispense medications directly to patients in a medically integrated model. The company partners with oncology, rheumatology, and other specialty clinics to deliver turnkey in-clinic pharmacy services including pharmacist staffing, EHR-integrated technology, prior authorization automation, financial assistance workflows, and operational support in exchange for recurring program fees.

Product overview

House Rx offers a unified cloud-based pharmacy management platform designed specifically for medically integrated dispensing in specialty clinics. The core House Rx Platform serves as the central system, integrating with clinic EHRs to connect prescribers and pharmacists. The platform comprises several integrated modules: Script Management for prescription processing, Dispensing Analytics Dashboards for operational insights, Prior Authorization Automation for AI-driven PA workflows, Patient Engagement Tools for scalable outreach, Financial Assistance Workflows for copay and grant support, and Drug Utilization Review for safety checking. Together, these components enable clinics to dispense specialty medications in-house while maintaining 95% medication adherence rates and reducing total healthcare costs by 13%.

Differentiator

Problem solved

Functional benefit

Products and services

• House Rx Platform Cloud-based pharmacy management platform built by specialty pharmacists and physicians that enables medically integrated dispensing. Integrates with clinic EHRs to support prior authorization, financial counseling, fulfillment, patient engagement, and real-time analytics for specialty medical practices.
• Script Management Module within the House Rx Platform that manages specialty medication prescriptions from receipt through fulfillment, enabling pharmacists and care coordinators to process scripts efficiently within the integrated care team workflow.
• Prior Authorization Automation AI-powered workflow automation that consolidates data from multiple sources, pre-populates authorization forms, tracks status, and sends renewal reminders to reduce administrative burden and avoid treatment gaps for specialty clinics.
• Financial Assistance Workflows Automation tools that screen patient eligibility, enroll patients in financial assistance programs, track grants and foundations, and optimize copays to reduce financial barriers to specialty therapy.
• Drug Utilization Review Clinical decision support module integrated with EHR data that automatically checks drug contraindications against patient allergies, medications, diagnoses, age, and pregnancy status and flags exceptions for pharmacist review.
• Dispensing Analytics Dashboards Real-time analytics dashboards built into the House Rx Platform that surface actionable insights from clinic dispensing data, tracking operational and quality metrics to optimize dispensing and clinical operations.
• Patient Engagement Tools Scalable patient engagement features including private chat/text with pharmacists, proactively coordinated refills, copay processing, pickup/delivery coordination, and digital side-effect and adherence monitoring.
• AI-Enabled Pharmacy Management Platform First AI-enabled pharmacy management platform announced in April 2025, incorporating artificial intelligence to automate prior authorization workflows, benefit investigation, and financial assistance enrollment for specialty clinics.

Quantifiable outcome

• 95% medication adherence rate observed in medically integrated dispensing model as compared to 70% in traditional specialty pharmacy
• +6 more outcomes

Named customers15 records

Segments3 records

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration4 records

AI capability4 records

Feature8 records

Partnerships

Ten partnerships are on record, tiered core and advisory.

• First Databank, Inc.coreTechnology or IntegrationLicensed FDB Databases of medical, pharmaceutical and nutritional information for sublicense to House Rx customers as part of the pharmacy management platform.
• Relay Health / SurescriptscoreTechnology or IntegrationLicensed services for pharmacy benefit management data and eligibility verification through the Surescripts network.
• CoverMyMedscoreTechnology or IntegrationLicensed prior authorization services including PA assistance, benefit verification, patient financial assistance, and prescription management.
• MoovcoreTechnology or IntegrationLicensed financial technology platform for payment processing and ACH transfers related to pharmacy transactions.
• Jeff Hunnicutt (Highlands Oncology Group)advisoryStrategic or Co-development PartnerCEO of Highlands Oncology Group serving as advisor. Provides strategic guidance on medically integrated dispensing from frontline oncology practice perspective.
• Josh Cox, PharmD, BCPS (Dayton Physicians Network)advisoryStrategic or Co-development PartnerDirector of Pharmacy and Research at Dayton Physicians Network serving as advisor. Brings pharmacy operations and clinical expertise.
• Alti Rahman (American Oncology Network)advisoryStrategic or Co-development PartnerChief Strategy & Innovation Officer at American Oncology Network serving as advisor on specialty pharmacy strategy.
• Bob Phelan (Cancer Specialists of North Florida)advisoryStrategic or Co-development PartnerCEO of Cancer Specialists of North Florida serving as advisor on oncology practice operations.
• Bobby Green, MD (Thyme Care)advisoryStrategic or Co-development PartnerPresident & Chief Medical Officer of Thyme Care serving as advisor on care coordination and clinical quality.
• Mark Nelson, PharmD (Northwest Medical Specialties)advisoryStrategic or Co-development PartnerCEO of Northwest Medical Specialties serving as advisor on pharmacy integration and practice management.

Scale indicators13 records

Recent moves8 records

Expansion highlights6 records

Emerging players

• Alto Pharmacy: Alto Pharmacy is a digital pharmacy platform focused on patient experience, free same-day delivery, and provider-friendly technology. While not clinic-embedded, it competes for specialty pharmacy share via technology-driven convenience and price transparency, overlapping with House Rx's technology-first, patient-centric approach.
• Arine: Arine is an AI-driven medication management platform serving health plans and providers to optimize medication therapy and adherence. It is comparable to House Rx in applying AI/automation to pharmacy and medication management workflows, though Arine is payer-focused rather than provider/clinic-embedded.
• Capsule: Capsule is a digital-first pharmacy offering same-day delivery and a technology-driven patient experience. It overlaps with House Rx in offering an alternative to traditional specialty pharmacy via technology, though Capsule is consumer-facing and primarily retail/specialty rather than clinic-embedded.

Broad incumbents

• Biologics by McKesson: Biologics by McKesson is an established specialty pharmacy focused on oncology, rheumatology, and other specialty conditions. As a McKesson-owned pharmacy, it operates at broader scale than House Rx and represents the incumbent distribution-and-specialty-pharmacy model House Rx's decentralized clinic-embedded approach challenges.
• US Bioservices (AmerisourceBergen / Cencora): US Bioservices, part of Cencora (formerly AmerisourceBergen), is a specialty pharmacy serving patients with chronic and complex conditions. It competes with House Rx in dispensing specialty medications and provides clinical and adherence support, but operates via centralized mail-order rather than clinic-embedded dispensing.
• CVS Specialty (Caremark): CVS Specialty, part of CVS Health, is one of the largest specialty pharmacy providers and is closely tied to the Caremark PBM. It represents the incumbent PBM-owned specialty pharmacy model that House Rx explicitly positions against as a decentralized alternative.

Direct peers

• Onco360: Onco360 is a specialty pharmacy focused on oncology and other complex conditions, providing oral oncolytic dispensing, patient education, and adherence support. While not clinic-embedded in the same way as House Rx, it competes for the same oncology specialty prescription volume and similar clinical outcomes.
• Trellis Rx (CPS Solutions): Trellis Rx (acquired by CPS Solutions) is a direct peer that provides technology-enabled specialty pharmacy services embedded in hospital outpatient clinics. Both companies focus on medically integrated dispensing for high-cost specialty drugs, leveraging EHR-integrated platforms to manage prior authorization and patient support.
• Shields Health Solutions: Shields Health Solutions is a direct peer — it partners with hospital systems and health systems to build and operate in-clinic/outpatient specialty pharmacies, with a similar model of embedding pharmacists into provider workflows and technology-enabled dispensing. Both target complex specialty medications and emphasize adherence and clinical outcomes.

Others

• RxBenefits: RxBenefits is a pharmacy benefits administrator focused on self-funded employer health plans, providing PBM procurement and management services. While not a direct dispensing competitor, it operates in the specialty pharmacy value chain and represents a potential partner or adjacent player for House Rx's specialty pharmacy services.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xx.com/TeamHouseRx
• Facebookfacebook.com/TeamHouseRx
• LinkedInlinkedin.com/company/house-rx
• Instagraminstagram.com/house.rx

Revenue estimate

Valuation estimate

Number of profiles

Profiles14 records

Funding overview

Funding rounds4 records

Investors10 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about House Rx